Evidence map›Paper›PMID 31610723›Full record

ArticleCirculation research2019

Impaired Autophagy in CD11b

Marc Clement, Juliette Raffort, Fabien Lareyre, Dimitrios Tsiantoulas, Stephen Newland, Yuning Lu, Leanne Masters, James Harrison, Svetlana Saveljeva, Marcella K L Ma and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Circulation research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Mitigating atherosclerosis: Integrating vaccines with gene targets.American heart journal plus : cardiology research and practice · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. The Evolving Role of Dendritic Cells in Atherosclerosis.International journal of molecular sciences · 2024
    Review
  9. Immune cell-mediated features of atherosclerosis.Frontiers in cardiovascular medicine · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Recent insights into atherosclerotic plaque cell autophagy.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Marc ClementFrom the Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom (M.C., J.R., F.L., D.T., S.N., Y.L., L.M., J.H., Z.M.).
Juliette RaffortFrom the Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom (M.C., J.R., F.L., D.T., S.N., Y.L., L.M., J.H., Z.M.).
Fabien LareyreFrom the Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom (M.C., J.R., F.L., D.T., S.N., Y.L., L.M., J.H., Z.M.).
Dimitrios TsiantoulasFrom the Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom (M.C., J.R., F.L., D.T., S.N., Y.L., L.M., J.H., Z.M.).
Stephen NewlandFrom the Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom (M.C., J.R., F.L., D.T., S.N., Y.L., L.M., J.H., Z.M.).
Yuning LuFrom the Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom (M.C., J.R., F.L., D.T., S.N., Y.L., L.M., J.H., Z.M.).
Leanne MastersFrom the Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom (M.C., J.R., F.L., D.T., S.N., Y.L., L.M., J.H., Z.M.).
James HarrisonFrom the Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom (M.C., J.R., F.L., D.T., S.N., Y.L., L.M., J.H., Z.M.).
Svetlana SaveljevaDepartment of Gastroenterology and Hepatology, University of Cambridge, United Kingdom (S.S., A.K.).
Marcella K L MaMRC Metabolic Diseases Unit, University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Genomics and Transcriptomics Core, Addenbrooke's Hospital, Cambridge, United Kingdom (M.K.L.M., B.Y.H.L., G.S.H.Y.).
Maria Ozsvar-KozmaDepartment of Laboratory Medicine, Medical University of Vienna and Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences Vienna, Austria (M.O.-K., C.J.B).
Brian Y H LamMRC Metabolic Diseases Unit, University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Genomics and Transcriptomics Core, Addenbrooke's Hospital, Cambridge, United Kingdom (M.K.L.M., B.Y.H.L., G.S.H.Y.).
Giles S H YeoMRC Metabolic Diseases Unit, University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Genomics and Transcriptomics Core, Addenbrooke's Hospital, Cambridge, United Kingdom (M.K.L.M., B.Y.H.L., G.S.H.Y.).
Christoph J BinderDepartment of Laboratory Medicine, Medical University of Vienna and Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences Vienna, Austria (M.O.-K., C.J.B).
Arthur KaserDepartment of Gastroenterology and Hepatology, University of Cambridge, United Kingdom (S.S., A.K.).
Ziad MallatFrom the Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom (M.C., J.R., F.L., D.T., S.N., Y.L., L.M., J.H., Z.M.).
University of Cambridge · GBCentre Méditerranéen de Médecine Moléculaire · FRWellcome Trust · GBAddenbrooke's Hospital · GBCeMM Research Center for Molecular Medicine · ATMedical University of Vienna · AT

Funding

British Heart Foundation RG/15/11/31593Medical Research Council MC_UU_00014/1Medical Research Council MC_UU_00014/5Medical Research Council MC_UU_12012/1Medical Research Council MC_UU_12012/5Wellcome Trust 106260/Z/14/Z
6 · The paper itself

Abstract

rationaleAtherosclerosis is a chronic inflammatory disease. Recent studies have shown that dysfunctional autophagy in endothelial cells, smooth muscle cells, and macrophages, plays a detrimental role during atherogenesis, leading to the suggestion that autophagy-stimulating approaches may provide benefit.

objectiveDendritic cells (DCs) are at the crossroad of innate and adaptive immune responses and profoundly modulate the development of atherosclerosis. Intriguingly, the role of autophagy in DC function during atherosclerosis and how the autophagy process would impact disease development has not been addressed. METHODS AND

resultsHere, we show that the autophagic flux in atherosclerosis-susceptible

conclusionsIn contrast to its proatherogenic role in macrophages, autophagy disruption in DCs induces a counter-regulatory response that maintains immune homeostasis in

Indexed as

AutophagyCell CommunicationCell ProliferationLymphocyte ActivationAnimalsAortaAortic DiseasesAtherosclerosisAutophagy-Related Protein 5Autophagy-Related ProteinsBone Marrow TransplantationCD11 AntigensCD11b AntigenCells, CulturedDendritic CellsDisease Models, AnimalAtg16l1 protein, mouseAtg5 protein, mouseAutophagy-Related Protein 5Autophagy-Related ProteinsCD11 AntigensCD11b AntigenClec9a protein, mouseItgam protein, mouseItgax protein, mouseLectins, C-TypeReceptors, ImmunologicReceptors, LDLatherosclerosisautophagydendritic cellsimmune systemmacrophages

Identifiers

PMID31610723
PMCPMC6844650
OpenAlexW2980818051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.